Protocol No.: DB-020-002

Title
Phase 1b Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Repeated Doses of DB-020 in Patients Receiving Cisplatin
Principal Investigator
Patel, Rusha
Phase
I
Age Group
Adult
Participating Institutions
Health Sciences Center
Mary Babb Randolph Cancer Center
Contacts
Aimie Jones, CCRC
Coordinator
Phone: +1 304-598-6135
Shannon Sampson
Coordinator
Phone: +1 304-598-4000 ext. 79634

View on ClinicalTrials.gov